Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2017 / Feb / Addressing a State of Disunion
Business & Entrepreneurship

Addressing a State of Disunion

The US travel ban strikes at the collaborative heart of science

By Charlotte Barker 02/15/2017 1 min read

Share

The prevailing theme of this issue is collaboration – from the growing analytical community of Africa, to Spanish and Finnish researchers teaming up to turn back time, to innovative academic–industry partnerships. In fact, collaboration could be mooted as a key theme of almost any issue of The Analytical Scientist, and indeed our sister titles in ophthalmology, drug manufacture, pathology and translational science. A few scientists may find teamwork challenging (see John Griffiths’s toe-curling stories of authorship acrimony), but most would agree that collaboration and exchange of ideas is the lifeblood of science. So it’s not surprising that news of President Trump’s ‘travel ban’ – an executive order restricting travel to the US of citizens from seven Muslim-majority countries – was greeted with dismay by many in the international scientific community (1)(2)(3)(4)(5)(6).

US universities, pharma companies, engineering firms and non-profits are a melting pot of nationalities. Now, thousands of scientists and engineers may find themselves unable to attend conferences or visit loved ones overseas for fear of being deported on their return. Labs are unable to welcome students, new employees or collaborators from the seven countries, nor meet them at the many international conferences held each year in the US. Though the executive order has now been blocked by the US courts, Trump remains determined to see the ban reinstated. Over 42,000 academics have signed a petition against the ban, including 62 Nobel Laureates (1). Some 180 US STEM organizations issued a joint letter condemning the executive order, and laying out the myriad ways it would harm science in America (2). The letter states: “Scientific progress depends on openness, transparency, and the free flow of ideas and people, and these principles have helped the United States attract and richly benefit from international scientific talent.”

As a supporting science, analytical chemistry is, by its very nature, collaborative. Milton Lee says, “That’s how you get creativity – by building up ideas together” – and anything that disrupts the free flow of ideas can only be bad for science. What’s your view on the ban? Have you or your colleagues been affected? Get in touch at [email protected].

Charlotte Barker

Editor

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Multisociety Letter on Immigration. Available at: http://bit.ly/2jx4HEe Academics Against Immigration Executive Order. http://bit.ly/2jI3khW JM Levin et al., “US immigration order strikes against biotech”, Trade Secrets Blog, Nature Biotechnology. Available at: http://go.nature.com/2ljXm7o Science Undivided. http://bit.ly/2l8kbxT Freedom of Science Network. http://bit.ly/2kkUMgF March for Science. http://bit.ly/2l0Vbp3

About the Author(s)

Charlotte Barker

After studying biology at Imperial College London, I got my start in biomedical publishing as a commissioning editor for healthcare journals, and I’ve spent my career covering everything from early-stage research to clinical medicine.

More Articles by Charlotte Barker

False

Advertisement

Recommended

False

Related Content

The Climate Conversation: Part Two – Michael Gonsior
Business & Entrepreneurship
The Climate Conversation: Part Two – Michael Gonsior

December 5, 2024

7 min read

In the second part of our interview, Michael Gonsior explores the pressing challenges in carbon cycle research, transformative tools and technologies, as well as analytical glimmers of hope

How to Succeed in Commercial Innovation
Business & Entrepreneurship
How to Succeed in Commercial Innovation

December 12, 2024

4 min read

Sell your story, stay alert, be careful who you hire, and focus intensely on execution

Green is Digital
Business & Entrepreneurship
Green is Digital

December 16, 2024

4 min read

Software tools can optimize resource management, streamline workflow processes, predict outcomes, and optimize experimental conditions – contributing to more sustainable laboratory operations

Could AI Ever Replace The Analytical Scientist?
Business & Entrepreneurship
Could AI Ever Replace The Analytical Scientist?

December 18, 2024

1 min read

Working closely with an ever-expanding network of experts helps keep our content relevant and engaging. And keeps artificial intelligence at bay, right?!

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.